Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron vs Metoclopramide for Chemotherapy-Induced Delayed Emesis
NCT00003213Phase 3Completed
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- May 1996
- Primary completion
- Apr 1999
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of granisetron, metoclopramide in chemotherapy-induced nausea and vomiting (CINV), sponsored by Swiss Group for Clinical Cancer Research. Started May 1996; status: completed.
02
Drugs
granisetronmetoclopramide
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00003213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003213.